Bright Minds Biosciences Inc (DRUG : NASDAQ)
Common Stock
$59.11
USD
+0.00 (%)
Last updated: 2026-09-17
Get DRUG alerts:
DRUG
Bright Minds Biosciences Inc
WealthAwesomePerformance
1 Day
-1.84%
1 Week
-9.15%
1 Month
-25.63%
YTD
-0.69%
Key Statistics
Market Cap
$579.99M
52W High
$123.75
52W Low
$48.90
P/E Ratio
-
50 Day MA
$74.02
200 Day MA
$77.98
Beta
-0.11
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $60.18 | $62.26 | $59.89 | $61.55 | $61.55 | 67,317 |
| 9/16/2026 | $60.22 | $61.08 | $57.58 | $59.11 | $59.11 | 97,437 |
| 9/15/2026 | $61.90 | $61.90 | $59.24 | $60.22 | $60.22 | 58,990 |
| 9/14/2026 | $63.30 | $63.90 | $62.83 | $63.38 | $63.38 | 42,154 |
| 9/11/2026 | $66.25 | $66.25 | $62.42 | $63.18 | $63.18 | 129,222 |
| 9/10/2026 | $63.98 | $66.00 | $63.19 | $65.00 | $65.00 | 86,700 |
| 9/9/2026 | $66.54 | $67.76 | $64.74 | $65.06 | $65.06 | 43,200 |
| 9/8/2026 | $65.07 | $67.77 | $64.30 | $66.91 | $66.91 | 65,200 |
| 9/4/2026 | $67.84 | $69.06 | $64.53 | $65.16 | $65.16 | 93,000 |
| 9/3/2026 | $71.95 | $71.97 | $67.25 | $68.02 | $68.02 | 131,300 |
Analyst Price Targets
Based on 6 analysts covering DRUG · as of Sep 17, 2026
Wall Street analysts forecast DRUG stock price to rise 184.9% over the next 12 months.
Consensus
Strong Buy4.67 / 5.00
Avg. Target
US$168.38
+184.9% Upside
Current Price
US$59.11
Last close
Analyst Breakdown (6 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DRUG's historical volatility
30-Day Vol
46.4%
Annualized
90-Day Vol
54.8%
Annualized
Trend (90d)
-23.7%
Annualized drift
90d Mean
US$56.55
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$59.83 | US$50.98 – US$70.23 |
| 60 trading days | US$58.17 | US$46.37 – US$72.96 |
| 90 trading days | US$56.55 | US$42.84 – US$74.63 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Bright Minds Biosciences Inc
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- -13.63%
- EPS (Diluted)
- -2.01
- Book Value
- 22.45
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About DRUG.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |